Whilst FDA has conducted acceptance and submitting assessments of many hundreds of PMTAs, it continues to be getting knowledge in making use of the statutory authorization common to PMTAs because few have contained sufficient information and facts to reach substantive evaluation. The primary aim on the proposed rule's information specifications is